|
⚲
|
| Keyboard |
| Daws D Ryan
✚
|
|
|---|---|
| CIK # | 0001598602 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001598602] | |
| 4 | [0001598602] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Daws D Ryan | |
| enGene Therapeutics Inc | |
| Concert Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2026-01-30 | Grant | 220,000 | $0.00 | |
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2025-01-29 | Grant | 280,000 | $0.00 | |
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2023-11-30 | Grant | 232,000 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
Employee Stock Option (right to buy) · derivative
|
2017-01-04 | Grant | 82,500 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
Employee Stock Option (right to buy) · derivative
|
2016-01-07 | Grant | 50,000 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
Employee Stock Option (right to buy) · derivative
|
2014-06-10 | Grant | 50,000 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
Employee Stock Option (right to buy) · derivative
|
2014-02-19 | Grant | 123,893 | $0.00 |